Robinhood(HOOD)
Search documents
Wall Street Bulls Look Optimistic About Robinhood Markets (HOOD): Should You Buy?
ZACKS· 2025-04-23 14:30
Let's take a look at what these Wall Street heavyweights have to say about Robinhood Markets, Inc. (HOOD) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Robinhood Market ...
Robinhood Markets, Inc. Investors: Company Investigated by the Portnoy Law Firm
GlobeNewswire News Room· 2025-04-22 22:38
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Robinhood Markets, Inc. ("Robinhood" or "the Company") (Nasdaq: HOOD) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Robinhood investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contac ...
Robinhood: The Next Generation Of Financial Services
Seeking Alpha· 2025-04-21 08:00
Robinhood's (NASDAQ: HOOD ) past year has been characterized by rapid top and bottom line growth. Despite this, the stock has recently sold off on fears that trading volumes will decline if the macroeconomic environment worsens. We believe the best days for RobinhoodAnalyst’s Disclosure: I/we have a beneficial long position in the shares of HOOD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it ...
Robinhood Strategies Could Be a Game-Changer for Young Investors
MarketBeat· 2025-04-12 12:36
Core Viewpoint - Robinhood Markets is launching new products aimed at diversifying revenue streams and driving growth, particularly targeting younger investors [2][3][12]. Group 1: Stock Performance - As of April 10, Robinhood's stock (HOOD) is down 5% since President Trump's Liberation Day announcement, outperforming the S&P 500 Index and the Financial Select Sector SPDR Fund, which are down 7% and 8.5% respectively [2]. - The current stock price is $43.68, with a 12-month price forecast of $55.06, indicating a potential upside of 26.05% [6]. Group 2: New Offerings - Robinhood has introduced three new offerings: Robinhood Strategies, Robinhood Banking, and Robinhood Cortex [3]. - Robinhood Strategies acts as an investment advisor, providing active portfolio monitoring with a low fee of 0.25% capped at $250 per year, significantly lower than traditional human advisors [4][5]. - The robo advisory market is estimated to grow from over $8 billion to nearly $33 billion by 2030, with Robinhood positioned to capture a share of this growth [8]. Group 3: Target Demographics - Approximately 75% of Robinhood Strategies' customer base consists of millennials or Gen Z, who are typically in the asset accumulation phase [7]. - The company is also expanding its banking services to cater to an aging customer demographic, with a median age increase from 31 to 35 years [9][10]. Group 4: Market Insights - Robinhood Banking will offer traditional banking services, which may appeal to users looking for family-oriented financial solutions, although the retail banking market is expected to grow at under 5% annually through 2029 [10]. - The Cortex offering utilizes AI to provide insights for active traders, which could be beneficial during volatile market conditions [11]. Group 5: Long-Term Growth Potential - The new offerings are seen as significant opportunities for long-term growth, although their immediate impact on stock value may be limited [12][13].
Robinhood Markets (HOOD) Moves 23.5% Higher: Will This Strength Last?
ZACKS· 2025-04-10 15:55
Company Overview - Robinhood Markets, Inc. (HOOD) shares increased by 23.5% in the last trading session, closing at $42.21, following a notable increase in trading volume compared to typical sessions [1] - The stock had previously experienced a 6% loss over the past four weeks [1] Market Influence - The sharp rally in Robinhood Markets shares was influenced by broad market strength after President Donald Trump's announcement of a 90-day suspension on tariffs for non-retaliating countries, which eased trade tensions and improved market sentiment [2] Earnings Expectations - The company is expected to report quarterly earnings of $0.35 per share, reflecting a year-over-year increase of 94.4% [3] - Revenues are projected to be $899.97 million, representing a 45.6% increase from the same quarter last year [3] Earnings Estimate Revisions - The consensus EPS estimate for Robinhood Markets has been revised 0.6% lower over the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [4] - The stock currently holds a Zacks Rank of 2 (Buy) [4] Industry Comparison - Robinhood Markets is part of the Zacks Financial - Investment Bank industry, where another stock, Tradeweb Markets (TW), closed 2% higher at $128.02, but has returned -7.3% over the past month [4] - Tradeweb's consensus EPS estimate has changed -1.4% over the past month to $0.85, which is a 19.7% increase compared to the previous year's EPS [5]
2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade
The Motley Fool· 2025-04-06 11:02
Market Overview - Equity markets have recently declined due to concerns over deteriorating macroeconomic conditions, particularly influenced by President Trump's trade wars, with the S&P 500 index down nearly 1.5% over the trailing-12-month period and a significant 13.8% drop so far this year [1] Company Performance: Summit Therapeutics - Summit Therapeutics is a clinical-stage biotech company with a market cap of $15.1 billion, notable for having no products on the market [3] - The company's leading candidate, ivonescimab, has shown strong clinical results, leading to a surge in share prices last year [3][5] - Summit has secured licensing rights for ivonescimab from Akeso Biopharma, allowing it to market the drug in multiple regions including North America and Europe [4] - Ivonescimab has already been approved in China and outperformed Keytruda in a phase 3 study for non-small cell lung cancer (NSCLC), a significant market for Keytruda [5] - The company is conducting several phase 3 studies for ivonescimab in the U.S. across various cancer types, indicating potential for future approvals and revenue growth [6][7] Company Performance: Robinhood Markets - Robinhood reported a 58% year-over-year revenue increase in 2024, reaching $2.95 billion, and achieved net earnings per share of $1.56, a turnaround from a loss of $0.61 the previous year [8] - The company's success has been partly attributed to crypto-related trading revenue, although it has shown growth in key metrics such as funded customers and assets under custody [9] - Robinhood is expanding its subscription service, Robinhood Gold, which ended the year with 2.6 million members, providing growth opportunities through increased spending on the platform [10] - The company has launched new products and made acquisitions, including the $300 million purchase of TradePMR, enhancing its position as a comprehensive financial services provider [11] - Despite a stock pullback this year, Robinhood is viewed as a strong long-term investment opportunity [12]
Huge News for Robinhood Stock: Why Growth Will Slow in Q1
The Motley Fool· 2025-04-05 12:00
Core Insights - The article discusses the financial positions and affiliations of Travis Hoium with Robinhood Markets and The Motley Fool, highlighting potential conflicts of interest in investment advice [1] Group 1 - Travis Hoium has positions in Robinhood Markets, indicating a personal financial stake in the company [1] - The Motley Fool has no position in any of the stocks mentioned, suggesting an impartial stance on the stocks discussed [1] - Travis Hoium is an affiliate of The Motley Fool and may receive compensation for promoting its services, which could influence his opinions [1]
Markets Shudder: Here's What Stocks Are Losing The Most In Tariff Selloff
Forbes· 2025-04-03 13:14
Core Viewpoint - The announcement of aggressive tariffs by President Donald Trump has led to a significant decline in stock markets, with major indexes facing their worst daily losses in years [1]. Market Impact - The Dow Jones Industrial Average fell by 2.8%, or 1,190 points, the S&P 500 decreased by 3.3%, and the Nasdaq dropped by 4.4%, marking the worst day for all three indexes since September 2022 [2]. - The "magnificent seven" tech companies experienced substantial losses, with Apple down 8%, Alphabet down 3%, Amazon down 6%, Meta down 7%, Microsoft down 2%, Nvidia down 6%, and Tesla down 4% [2]. Sector Performance - Retail stocks also suffered, with Walmart, Costco, and Home Depot losing 2% or more, while Lululemon and Nike saw declines close to 10% due to their manufacturing reliance on China and Vietnam, which are heavily targeted by the new tariffs [3]. - Financial services companies faced declines as well, with American Express down 7%, JPMorgan Chase down 5%, and Robinhood down 8% [3]. Bond Market Reaction - U.S. government bonds rallied as investors sought safer assets, leading to a decline in yields for the benchmark 10-year Treasury by more than 15 basis points to just above 4%, the lowest level since before the election [4]. Specific Company Analysis - Apple is particularly affected, facing an estimated $39.5 billion in tariff costs, which could result in a 32% hit to earnings. Analysts speculate that a carveout for Apple may be necessary due to its significant non-U.S. manufacturing [5]. - The total market value loss for the "magnificent seven" was approximately $784 billion, with Apple's loss alone accounting for $263 billion [6]. Strategic Outlook - Wall Street strategists have raised concerns about the likelihood of a bear market, with UBS setting a target of 5,300 for the S&P, indicating a potential further decline of 4% from premarket levels. Bank of America's top equity strategist noted the absence of a clear tariff playbook [7].
Is Now the Time to Buy Robinhood Stock?
The Motley Fool· 2025-04-03 08:20
Group 1: Company Overview - Robinhood Markets is a discount broker that has expanded its services to include stock, options, cryptocurrency trading, banking services, prediction markets, and retirement investing, with assets under custody rising 88% year over year to $193 billion in Q4 2024 [2] - The average customer account size at Robinhood is $7,700, indicating that it attracts relatively new investors [3] Group 2: Financial Performance - In 2024, Robinhood's revenue increased by 58%, and earnings per share rose to $1.56 from a loss of $0.61 in 2023, showcasing strong business performance [4] - The company's price-to-earnings ratio is approximately 28.5, compared to 22.5 for Charles Schwab, reflecting a premium valuation likely due to its growth [8] Group 3: Market Risks - Robinhood has not yet experienced a significant market downturn as a public company, raising concerns about its resilience during adverse market conditions [5] - The stock has lost 30% of its value in 2025, primarily during a market correction, while Schwab's stock has only decreased by less than 5% [10] - The average account size suggests that Robinhood's investors are younger and less experienced, which could lead to higher exit rates during a bear market [11][12]
Robinhood Is Changing the Game
The Motley Fool· 2025-04-02 12:51
Core Insights - Robinhood has introduced new products for its Gold customers, including investment planning and banking services, which could significantly enhance its competitive position in the finance industry [1] Group 1: Product Offerings - The new products aim to attract more customers and increase assets under custody for Robinhood [1] Group 2: Market Impact - The introduction of these services is expected to change the game for Robinhood in the financial sector, potentially leading to increased market share [1]